Last week, Chinese e-commerce giant Alibaba and its U.S. payment processor agreed to pay $600 million to settle U.S. government allegations that they let merchants use their platforms to smuggle illegal pharmaceuticals and pill presses into the United States.
You don't have access to this post on China Trade Monitor at the moment, but if you upgrade your account you'll be able to see the whole thing, as well as all the other posts in the archive! Subscribing only takes a few seconds and will give you immediate access.
This post is for subscribers only
Subscribe now
Already have an account? Sign in
